AGP Executive Report
Last update: 37 minutes agoEbola Vaccine Logistics: DR Congo received 16,520 doses of Merck’s Ervebo vaccine in Kinshasa, with more shipments expected, as the country battles its deadliest Ebola outbreak on record. Strain Challenge: Ervebo is approved for the Zaire strain, while the current outbreak is driven by the Bundibugyo strain; WHO says protection is still uncertain, so 20,000 doses are earmarked for a Phase 3 trial and 50,000 for frontline and health workers. Surveillance Push: Africa CDC warns the official case count may reflect only 30–40% of infections, estimating the outbreak could be 10,000–15,000 cases, prompting DR Congo to launch “Congo River Without Ebola” to tighten checks at ports and along river routes. Capital Risk Management: Health teams are stepping up screening for people arriving from affected areas near Kinshasa, where officials fear the virus could spread despite no cases reported so far. Frontline Strain: Health workers describe fear, burnout, and unpaid wages while treating patients, underscoring how staffing and support gaps are complicating the response.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
